DK142053B - Process for preparing racemic or optically active indane or perhydronaphthalene derivatives. - Google Patents

Process for preparing racemic or optically active indane or perhydronaphthalene derivatives. Download PDF

Info

Publication number
DK142053B
DK142053B DK154372A DK154372A DK142053B DK 142053 B DK142053 B DK 142053B DK 154372 A DK154372 A DK 154372A DK 154372 A DK154372 A DK 154372A DK 142053 B DK142053 B DK 142053B
Authority
DK
Denmark
Prior art keywords
reaction
general formula
acid
carried out
compounds
Prior art date
Application number
DK154372A
Other languages
Danish (da)
Other versions
DK142053C (en
Inventor
Zoltan George Hajos
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US765023A external-priority patent/US3897460A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to DK154372A priority Critical patent/DK142053B/en
Publication of DK142053B publication Critical patent/DK142053B/en
Application granted granted Critical
Publication of DK142053C publication Critical patent/DK142053C/da

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

(11) FREMLÆGGELSESSKRIFT 1U2053 DANMARK lntc'·3 c II c «S/βΓ i (21) Ansøgning nr. 15^5/72 (22) Indleveret døn 29* mar. 1972 (23) Løbedag 2. Qkt. 19^9 (44) Ansøgningen fremlagt og Q ^ fremlæggelsesskrlftet offentliggjort den * O* »Ug* 1 yOv PATENT-OG VAREMÆRKEVÆSENET Woritet begeer« fra ^n(11) PUBLICATION WRITING 1U2053 DENMARK lntc '· 3 c II c «S / βΓ i (21) Application No. 15 ^ 5/72 (22) Filed Done 29 * Mar. 1972 (23) Race day 2. Qkt. 19 ^ 9 (44) The application presented and the Q ^ publication published on * O * »Ug * 1 yOv THE PATENT AND TRADEMARKETS Woritet begs« from ^ n

4. okt. i960, 7o5Q22, USOct 4 i960, 7o5Q22, US

(71) F. HOFFMA.NN-LA ROCHE & CO. AKTIENGESELLSCHART, Grenzacherstraøøe 124“184, Postfach CH-4002 Basal, CH, (72) Opfinder: Zoltan George Hajos, 24^ Highland Avenue, Upper Montclair, N.J., US.(71) F. HOFFMA.NN-LA ROCHE & CO. AKTIENGESELLSCHART, Grenzacherstraøe 124 “184, Post Box CH-4002 Basal, CH, (72) Inventor: Zoltan George Hajos, 24 ^ Highland Avenue, Upper Montclair, N. J., US.

(74) Fuldmægtig under sagens behandling:(74) Plenipotentiary in the proceedings:

Plougmann & Vlngtoft Patentbureau · (54) Fremgangsmåde til fremstilling af racemlske eller optisk aktive in* dan- eller perhydronaphthalenderivater.Plougmann & Vlngtoft Patent Bureau · (54) Process for the preparation of racemic or optically active in-dan or perhydronaphthalane derivatives.

Den foreliggende opfindelse angår en særlig fremgangsmåde til fremstilling af hidtil ukendte racemiske eller optisk aktive indan- eller perhydronaphthaienderivater med den almene formel IThe present invention relates to a particular process for the preparation of novel racemic or optically active indane or perhydronaphthalene derivatives of the general formula I

R4R4

ch2HCH2

hvor R4 betegner hydrogen eller alkyl med 1-7 carbonatomer, Z betegner carbonyl, alkylendioxymethylen med 1-6 carbonatomer 2 142053 p p i alkylendelen eller CH(OR ), R betegner hydrogen, alkyl med 1- 7 earhonatomer, alkoxyalkyl med 1-7 carhonatomer i hver alkyldel, phenylalkyl med 1-7 earhonatomer i alkyldelen, alka= noyl med 1-6 earhonatomer, benzoyl, nitrobenzoyl med 1 eller 2 nitrogrupper, trifluoracetyl eller camphersulfonyl, og m betegner 1 eller 2. I de her viste formler er de forskellige substituenter knyttet til den cycliske kerne ved enten en fuldt optrukken linje, hvilket angiver en substituent, som er i β-stilling, dvs. over papirets plan, eller ved en stiplet linje, hvilket angiver en substituent, som er i α-stilling, dvs. under papirets plan.where R4 represents hydrogen or alkyl of 1-7 carbon atoms, Z represents carbonyl, alkylenedioxymethylene of 1-6 carbon atoms or CH (OR), R represents hydrogen, alkyl of 1-7 carbon atoms, alkoxyalkyl of 1-7 carbon atoms. each alkyl moiety, phenylalkyl having 1-7 earh atoms in the alkyl moiety, alkanoyl having 1-6 earh atoms, benzoyl, nitrobenzoyl having 1 or 2 nitro groups, trifluoroacetyl or camphorsulfonyl, and m represents 1 or 2. In the formulas shown herein, the various substituents are attached to the cyclic nucleus by either a fully drawn line, indicating a substituent which is in the β position, i. above the plane of the paper, or by a dashed line, indicating a substituent which is in the α position, i. under the plan of the paper.

Som eksempler på alkylgrupper med 1-7 earhonatomer kan nævnes methyl, ethyl, isopropyl, n-propyl og tert.butyl. Eksempler på alkoxyalkylgrupper med 1-7 earhonatomer i hver alkyldel er 2- ethoxy-ethyl og 3-propoxy-propyl. Eksempler på alkanoylgrupper med 1-6 earhonatomer er acetyl og propionyl. Eksempler på alky= lendioxygrupper,hvis alkylendel indeholder 1-6 earhonatomer, er 1,2-ethylendioxy, 2,2-dimethyl-l,3-propylendioxy, l,2-propy= lendioxy og 2,3-butylendioxy. Eksempler på nitrobenzoylgrupper med 1 eller 2 nitrogrupper er 4-&itrobenzoyl og 3,5-dinitroben= zoyl.Examples of alkyl groups having 1-7 earhone atoms include methyl, ethyl, isopropyl, n-propyl and tert-butyl. Examples of alkoxyalkyl groups having 1-7 earhone atoms in each alkyl moiety are 2- ethoxyethyl and 3-propoxy propyl. Examples of alkanoyl groups having 1-6 earhone atoms are acetyl and propionyl. Examples of alkylene dioxide groups whose alkylene moiety contains 1-6 earhone atoms are 1,2-ethylenedioxy, 2,2-dimethyl-1,3-propylenedioxy, 1,2-propylenedioxy and 2,3-butylenedioxy. Examples of nitrobenzoyl groups having 1 or 2 nitro groups are 4- & itrobenzoyl and 3,5-dinitroben = zoyl.

Eremgangsmåden ifølge opfindelsen til fremstilling af forbindelserne med den ovenfor viste almene formel I er ejendommelig ved, at man hydrogenerer en. forbindelse med den almene formel IIIThe process according to the invention for the preparation of the compounds of the general formula I shown above is characterized by hydrogenating one. compound of the general formula III

R4 Z ' «f2>mR4 Z '«f2> m

IIIIII

COOHCOOH

hvor R4, Z og m har de ovenfor anførte betydninger, i nærværelse af en ædelmetalkatalysator i et indifferent organisk opløsningsmiddel, opløser den vundne forbindelse med den almene formel IIwherein R 4, Z and m have the above meanings, in the presence of a noble metal catalyst in an inert organic solvent, the compound obtained with the general formula II dissolves

3 142053 Η4 H \CH2^m ,A|A-'3 142053 Η4 H \ CH2 ^ m, A | A- '

! H! H

COOHCOOH

4 hvor R , Z og m har de ovenfor anførte betydninger, som racemat eller en optisk enantiomer i et aprot, polært opløsningsmiddel, som for« trinsvis er dimethylsulfoxid eller an blanding af dimethylsulfoxid og et andet aprot, polært opløsningsmiddel, og derpå til reaktions* blandingen sætter formaldehyd i nærværelse af en primær amin eller en sekundær amin eller syreadditionssalte deraf.4 wherein R, Z and m have the above meanings as racemate or an optical enantiomer in an aprotic polar solvent which is preferably "dimethylsulfoxide or a mixture of dimethylsulfoxide and another aprotic polar solvent, and then to reaction * the mixture substitutes formaldehyde in the presence of a primary amine or a secondary amine or acid addition salts thereof.

Den reaktionssekvens, som går ud fra de hidtil ukendte forbindelser med den almene formel III og fører til de hidtil ukendte forbindel* ser med den almene formel I, er en del af en fuldstændig ny, øko= nomisk værdifuld totalsyntese af steroider. Det har ikke i den kendte teknik været foreslået at anvende forbindelser af typen med den almene formel I som mellemprodukter ved en sådan totalsynteee. Hydrogeneringen af bicycliske β-ketosyreestere til dannelse af trans-substituerede bicycliske forbindelser er beskrevet af lominé et al., Bulletin de la Société Chimique de France, 9» 3664 (1968).The reaction sequence, which is based on the novel compounds of general formula III and which leads to the novel compounds of general formula I, is part of a completely new, economically valuable total synthesis of steroids. It has not been proposed in the prior art to use compounds of the general formula I as intermediates in such a total synthesis. The hydrogenation of bicyclic β-ketoacid esters to form trans-substituted bicyclic compounds is described by Lominé et al., Bulletin de la Société Chimique de France, 9 »3664 (1968).

Den her omhandlede omdannelse af en forbindelse med den almene formel III til en forbindelse med den almene formel II i højt udbytte ved katalytisk hydrogenering er imidlertid overraskende af den grund, at der måtte forventes kraftig decarboxylering under de anvendte reaktionsbetingelser, når den frie syre anvendes.However, the conversion of a compound of general formula III into a compound of general formula II in high yield by catalytic hydrogenation is, however, surprising because strong decarboxylation under the reaction conditions used when the free acid is to be expected.

Endvidere var dannelsen af forbindelserne med den almene formel 1 ud fra forbindelser med den almene formel II overraskende under de anvendte betingelser for en Mannich-reaktion, eftersom det er ble= vet anført, at reaktionen måtte forventes at føre til den tilsva= rende β-aminoketon, jfr. f.eks. C. Mannich et al., Chem. Ber., 57, 1108 (1924) og Marshall et al., J. Org. Chem., 30, 3475 (1965).Furthermore, the formation of the compounds of the general formula 1 from compounds of the general formula II was surprisingly under the conditions of a Mannich reaction, since it has been stated that the reaction was expected to lead to the corresponding β aminoketone, cf. eg. C. Mannich et al., Chem. Ber., 57, 1108 (1924) and Marshall et al., J. Org. Chem., 30, 3475 (1965).

Omdannelsen af en forbindelse med den almene formel II til den 4-methylen-trans-kondenserede forbindelse med den almene formel 4 142053 I udføres ved en modificeret Mannich-reaktion. Omdannelsen kan udføres under anvendelse af formaldehyd i nærværelse af primære eller sekundære aminsyreadditionssalte. Egnede salte er sådanne, som er afledt af stærke mineralsyrer eller organiske syrer, f.eks. hydrogenhalogenider, fortrinsvis hydrogenchlorid, svovlsyre eller oxalsyre. Reaktionen udføres hensigtsmæssigt ved en temperatur i området fra 0°C til ca. 80°C. Et ifølge opfindelsen foretruk= ket temperaturområde til denne omsætning er 15 - 40°C, da det er det mest hensigtsmæssige og giver de bedste resultater. Selv om mængdeforholdet mellem de til denne reaktion anvendte reak= tanter ikke er kritisk, har det vist sig fordelagtigt at anvende et molforhold mellem formaldehyd og ketosyre på ca. 10:1 og et molforhold mellem amin og ketosyre på fra 0,1:1 til 1:1.The conversion of a compound of general formula II to the 4-methylene trans-fused compound of general formula 4 is carried out by a modified Mannich reaction. The conversion can be carried out using formaldehyde in the presence of primary or secondary amino acid addition salts. Suitable salts are those derived from strong mineral acids or organic acids, e.g. hydrogen halides, preferably hydrogen chloride, sulfuric acid or oxalic acid. The reaction is conveniently carried out at a temperature in the range of 0 ° C to approx. 80 ° C. A preferred temperature range according to the invention for this reaction is 15 - 40 ° C, as it is the most convenient and gives the best results. Although the amount ratio of the reactants used for this reaction is not critical, it has been found advantageous to use a molar ratio of formaldehyde to keto acid of approx. 10: 1 and a mole ratio of amine to keto acid of 0.1: 1 to 1: 1.

Reaktionen udføres bedst i et sådant aprot opløsningsmiddel, som virker både som opløsningsmiddel for reaktionen og som de= carboxyleringsmiddel. Særlig gode resultater opnås, når for= bindeisen med den almene formel II lades reagere med det Mannich-system, der dannes ved addition af formaldehyd og et primært eller sekundært aminsalt i dimethylsulfoxid; anionen af forbindelsen med den almene formel II dannes først i dimethylsulfoxidet, og den undertrykkes in situ med Mannich= -systemet. Vandigt formalin (37 - 40^'s) er en i almindelighed tilfredsstillende formaldehydkilde for denne reaktion. Eksemp= ler på de til denne reaktion egnede aminer er sekundære aminer såsom diethylamin, morpholin, piperidin og pyrrolidin, og pri= mære aminer såsom methylamin, butylamin og benzylamim En sær= lig foretrukken amin til denne omsætning er piperidin. indre aprote opløsningsmidler, f.eks. dimethylformamid og hexamethylphosphor= amid, som er indifferente over for reaktanterne, kan anvendes i forbindelse med dimethylsulfoxidet. Eet dimethylsulfoxidholdige opløsningsmiddel fremmer decarboxyleringen, som fremkalder eno= lisering ved den stilling, hvor carboxygruppen er tilknyttet; undertrykkelsen med Mannich-systernet i dimethylsulfoxid tilla= der ikke enolen at ækvilibrere i retning mod den foretrukne stilling i det trans-kondenserede bicycliske system.The reaction is best carried out in such an aprotic solvent which acts both as a solvent for the reaction and as a carboxylating agent. Particularly good results are obtained when the compound of general formula II is allowed to react with the Mannich system formed by the addition of formaldehyde and a primary or secondary amine salt in dimethyl sulfoxide; the anion of the compound of general formula II is first formed in the dimethyl sulfoxide and it is suppressed in situ by the Mannich = system. Aqueous formalin (37 - 40 µs) is a generally satisfactory source of formaldehyde for this reaction. Examples of the amines suitable for this reaction are secondary amines such as diethylamine, morpholine, piperidine and pyrrolidine, and primary amines such as methylamine, butylamine and benzylamine. A particularly preferred amine for this reaction is piperidine. internal aprotic solvents, e.g. dimethylformamide and hexamethylphosphorus amide, which are inert to the reactants, may be used in conjunction with the dimethyl sulfoxide. One dimethyl sulfoxide-containing solvent promotes decarboxylation which induces enolization at the position where the carboxy group is attached; the suppression with the Mannich system in dimethylsulfoxide does not allow the enol to equilibrate toward the preferred position in the trans-fused bicyclic system.

5 1420535 142053

Det er en særlig fordel, at hydrogeneringen af forbindelserne med den almene formel III til dannelse af en trans-kondenseret bicyclisk struktur kan udføres under opnåelse af yderst høje udbytter. Hydrogeneringen udføres i nærværelse af en ædelmetal= katalysator såsom palladium, rhodium, iridium eller platin. Især foretrækkes en palladiumkatalysator. Ædelmetalkatalysatoren kan anvendes med eller uden bærer, og såfremt der anvendes bærer, er konventionelle bærere velegnede. Det foretrækkes at anvende palla= dium på barium- eller calciumsulfat, og ifølge opfindelsen fore= trækkes det specielt at anvende palladium på bariumsulfat, da den= ne gængse og let tilgængelige katalysator har vist sig at give gode resultater i praksis. Især foretrækkes lOj^s Pd/BaSO^. Por= holdet mellem katalysator og substrat er ikke kritisk og kan vari= eres, men det har vist sig fordelagtigt at anvende et vægtfor= hold mellem katalysator og substrat på fra ca. 1:1 til ca. 1:10.It is a particular advantage that the hydrogenation of the compounds of the general formula III to form a trans-fused bicyclic structure can be carried out to obtain extremely high yields. The hydrogenation is carried out in the presence of a precious metal catalyst such as palladium, rhodium, iridium or platinum. In particular, a palladium catalyst is preferred. The precious metal catalyst can be used with or without carrier, and if carrier is used, conventional carriers are suitable. It is preferred to use palladium on barium or calcium sulfate, and according to the invention, it is particularly preferred to use palladium on barium sulfate, as this common and readily available catalyst has been found to give good results in practice. Particularly preferred is P10 / BaSO4. The pore ratio of catalyst to substrate is not critical and can be varied, but it has been found advantageous to use a weight ratio of catalyst to substrate of from approx. 1: 1 to approx. 1:10.

Især foretrækkes et forhold på 1:3. Hydrogeneringen udføres i nærværelse af et inert organisk opløsningsmiddel for den bestem= te forbindelse med den almene formel III, som hydrogeneres, f.eks. en lavere alkanol såsom methanol, isopropanol eller octa= nol, ketoner, f.eks. lavere dialkylketoner såsom acetone eller methylethylketon, lavere alkylestere af lavere alkansyrer, f.eks. ethylacetat, lavere alkylethere såsom diethylether eller tetrahydrofuran og aromatiske carbonhydrider såsom toluen eller benzen. Det foretrækkes især at udføre hydrogeneringen under anvendelse af en lavere alkanol som opløsningsmiddel, og hydrogeneringen udføres fortrinsvis under ikke-sure betingelser, idet den hensigtsmæssigt udføres under neutrale betingelser. Hydrogeneringen kan udføres ved atmosfæretryk eller ved tryk under eller over atmosfæretryk, f.ekB. ved så høje tryk som ca. 50 atmosfærer. Desuden kan hydrogeneringen udføres ved stuetemperatur eller ved temperaturer under eller over ( stuetemperatur'; hydrogeneringen udføres hensigtsmæssigt ved stuetemperatur. Bydrogeneringen udføreB under anvendelse af konventionelle metoder. Hydrogeneringen bør afbrydes efter op= tagelse af den ækvivalente hydrogenmængde; hvis absorptionen af hydrogen ophører, før der er optaget et ækvivalent hydrogen, er det fordelagtigt da at tilsætte mere katalysator og hydroge= nere videre. Det vil forstås, at et andet væsentligt træk ved dette hydrogeneringstrin er, at hydrogeneringen af forbindelsen med den almene formel III til dannelse af forbindelsen med den % 6 142053 almene formel II forløber uden væsentlig decarboxylering af den sub= stituerede forbindelse med den almene formel III. Afhængigt af de anvendte hydrogeneringsbetingelser kan gruppen Z i forbindelsen med den almene formel III modificeres under hydrogeneringen. Hvis f.eks. Z betegner en gruppe 0H(0R2), hvor R2 er alkoxyalkyl, kan 2 gruppen R under de ovenfor beskrevne hydrogeneringsbetingelser o fraspaltes under hydrogeneringen. En foretrukken gruppe R til udførelse af hydrogeneringen er alkyl, især tert.butyl. Ifølge opfindelsen foretrækkes det, at R2 er tert.butyl, og at R^ er methyl eller ethyl, idet tert.butoxy^beskyttelsesgruppen særlig let kan indføres og igen fraspaltes, og idet R^ = methyl eller ethyl svarer til de mest interessante steroider, der fremstilles ud fra forbindelserne I, jfr. nedenfor.In particular, a ratio of 1: 3 is preferred. The hydrogenation is carried out in the presence of an inert organic solvent for the particular compound of the general formula III which is hydrogenated, e.g. a lower alkanol such as methanol, isopropanol or octanol, ketones, e.g. lower dialkyl ketones such as acetone or methyl ethyl ketone; lower alkyl esters of lower alkanoic acids, e.g. ethyl acetate, lower alkyl ethers such as diethyl ether or tetrahydrofuran and aromatic hydrocarbons such as toluene or benzene. It is particularly preferred to carry out the hydrogenation using a lower alkanol as solvent, and the hydrogenation is preferably carried out under non-acidic conditions, suitably carried out under neutral conditions. The hydrogenation can be carried out at atmospheric pressure or at or below atmospheric pressure, e.g. at as high pressures as approx. 50 atmospheres. In addition, hydrogenation can be carried out at room temperature or at temperatures below or above (room temperature '; hydrogenation is conveniently carried out at room temperature. when an equivalent hydrogen is taken up, it is advantageous then to add more catalyst and hydrogenation further.It is understood that another essential feature of this hydrogenation step is that the hydrogenation of the compound of the general formula III to form the compound with the% The general formula II proceeds without substantial decarboxylation of the substituted compound of the general formula III, depending on the hydrogenation conditions used, the group Z of the compound of the general formula III may be modified during the hydrogenation. (OR2) where R2 is alkoxyalkyl can 2 the group R under the hydrogenation conditions described above is decomposed during the hydrogenation. A preferred group R for carrying out the hydrogenation is alkyl, especially tert-butyl. According to the invention, it is preferred that R 2 is tert-butyl and that R 1 is methyl or ethyl, the tert-butoxy 2 protecting group being particularly easily introduced and again cleaved, and R 2 = methyl or ethyl corresponding to the most interesting steroids. prepared from compounds I, cf. below.

Forbindelser med den almene formel III kan fremstilles ud fra forbindelser med den almene formel V'Compounds of general formula III can be prepared from compounds of general formula V '

Xt>’· hvor R^, Z og· m har de ovenfor anførte betydninger.Xt> where R 1, Z and m have the above meanings.

Mange af de udgangsmaterialer med den almene formel V, hvor Z er en carbonylforbindelse, er kendte forbindelser. Indanonud= gangsforbindelserne med den almene formel Y, hvor Z er en carbo= nylforbindelse, kan hensigtsmæssigt fremstilles ved kendte metoder, f.eks. ved Michael-addition af methylvinylketon til 2-alkyl-cyclopentan-l,3-dion. Cycliseringen kan udføres under anvendelse af pyrrolidin i et benzenopløsningsmiddel under tilbagesvalingsbetingelser (jfr. USA patentskrift nr. 3.321.488).Many of the starting materials of general formula V in which Z is a carbonyl compound are known compounds. The indanone starting compounds of general formula Y, wherein Z is a carbonyl compound, may conveniently be prepared by known methods, e.g. by Michael addition of methyl vinyl ketone to 2-alkyl-cyclopentane-1,3-dione. The cyclization can be carried out using pyrrolidine in a benzene solvent under reflux conditions (cf. U.S. Pat. No. 3,321,488).

Om ønsket, kan der fremstilles andre derivater af forbindelserne med den almene formel Y. Således kan man til fremstilling af de derivater, hvor OR er en hydroxygruppe, reducere den tilsvarende oxogruppe selektivt med et lithiumaluminium--tri-(lavere alkoxy)= -hydrid eller alkalimetalborhydrid, f.eks. natrium- eller kali= 2 umborhydrid, ved lave temperaturer. Derivater, hvor OR er en alkoxygruppe med 1-7 carbonatomer, f.eks. tert.butoxy, kan frem= stilles ud fra det tilsvarende hydroxyderivat ved omsætning under sure betingelser med isobutyletf efter i og for sig kendte metoder.If desired, other derivatives of the compounds of general formula Y. may be prepared. Thus, to prepare the derivatives wherein OR is a hydroxy group, the corresponding oxo group can be selectively reduced with a lithium aluminum tri (lower alkoxy) = hydride. or alkali metal borohydride, e.g. sodium or potassium = 2 umbohydride, at low temperatures. Derivatives wherein OR is an alkoxy group of 1-7 carbon atoms, e.g. tert-butoxy, can be prepared from the corresponding hydroxy derivative by reaction under acidic conditions with isobutyl ether by methods known per se.

7 1420537 142053

Andre derivater svarende til definitionen af Z kan fremstilles ved i og for sig kendte metoder.Other derivatives corresponding to the definition of Z can be prepared by methods known per se.

Den bicycliske keton med den almene formel V kan omdannes til sure forbindelser med den almene formel III ved omsætning med en base, som er tilstrækkelig stærk til at danne den tilsvarende anion af den bicycliske forbindelse via dannelse af konjugatenolat. Eksempler på baser, der egner' sig til denne omsætning, er alkali« metalamider, såsom natriumamid, alkalimetalalkoxider Båsom lithi« ummethoxid og alkalimetalhydrider såsom natriumhydrid. Det fore« trækkes almindeligvis at udføre denne reaktion ved stuetemperatur, selv om der også kan anvendes temperaturer fra ca. -40°C til re= aktionsblandingens kogepunkt. Reaktionen udføres hensigtsmæssigt i flydende ammoniak eller i nærværelse af et organisk opløsnings« middel, som er indifferent over for reaktanter, f.eks. dimethyl«, sulfoxid eller dimethylformamid, carbonhydrider, f.eks. benzen eller toluen, eller ethere, f.eks. diethylether eller tetrahydro« furan. Et foretrukket opløsningsmiddel til denne omsætning er dimethylsulfoxid. Dette reaktionsprodukt, det bicycliske enolat« «mellemprodukt, kan isoleres ved konventionelle 'metoder, f.’eks.' ved fjernelse af opløsningsmidlet under anvendelse af vakuumde« stillation.The bicyclic ketone of general formula V can be converted to acidic compounds of general formula III by reaction with a base sufficiently strong to form the corresponding anion of the bicyclic compound via formation of conjugatenolate. Examples of bases suitable for this reaction are alkali metal amides such as sodium amide, alkali metal alkoxides such as lithium metal oxide and alkali metal hydrides such as sodium hydride. It is generally preferred to carry out this reaction at room temperature, although temperatures of approx. -40 ° C to the reaction boiling point. The reaction is conveniently carried out in liquid ammonia or in the presence of an organic solvent which is inert to reactants, e.g. dimethyl ', sulfoxide or dimethylformamide, hydrocarbons, e.g. benzene or toluene, or ethers, e.g. diethyl ether or tetrahydrofuran. A preferred solvent for this reaction is dimethyl sulfoxide. This reaction product, the bicyclic enolate "" intermediate, can be isolated by conventional "methods, e.g. by removal of the solvent using vacuum dehydrogenation.

Den anion, der på denne måde fås i remanensen, kan carboxyleres ved omsætning med overskud af carbondioxid, hvorved der fås carboxylsyren med den almene formel III. Carboxylerin« gen kan hensigtsmæssigt udføres ved anvendelse af fast carbon« dioxid ("tøris") eller ved at føre gasformigt carbondioxid ned i reaktionsblandingen. Eksempler på velegnede opløsningsmidler til denne omsætning er et hvilket som helst af de ovennævnte opløsningsmidler, der kan anvendes til fremstilling af anionen, med undtagelse af flydende ammoniak, som er basisk, og dimethyl« · sulfoxid, som synes at fremme decarboxyleringen. I tilfælde, hvor der anvendes flydende ammoniak eller dimethylsulfoxid til frem« stilling af anionen, bør de erstattes med et indifferent opløs« ningsmiddel, når behandlingen med carbondioxid udføres. Egnede reaktionstemperaturer ligger i området fra -60°C til ca. 40°C. Reaktionen udføres fortrinsvis til at begynde med i den nedre ende af dette område i et tidsrum på ca. 6 timer, hvorefter 8 142053 reaktionsblandingen får lov at opvarmes til omtrentlig stuetem= peratur i løbet af 4 timer og derefter henstår ved stuetempera= tur i yderligere 12 timer. Eraskillelsen af det ønskede reak= tionsprodukt fra reaktionsblandingen kan udføres ved ekstraktion. Ekstraktionen udføres hensigtsmæssigt fra et carbonhydridop= løsningsmiddel med en fortyndet base såsom natriumhydroxid el= ler lithiumcarbonat, hvorved der dannes det tilsvarende vand= opløselige salt af syren. Baseekstraktion anvendes til fjernelse af det ønskede produkt fra udgangsmaterialet. Den vandige fase fraskilles og syrnes forsigtigt til en pH-værdi mellem 2,5 og 4,5 med fortyndet mineralsyre, hvorefter det ønskede produkt fås ved konventionelle metoder. Selv om reaktionen på hensigtsmæssig måde kan udføres ved atmosfæretryk, kan der opnås højere udbytter ved at udføre reaktionen under højere tryk, f.eks. tryk i området 30 - 40 kg/cm^.The anion thus obtained in the residue can be carboxylated by reaction with excess carbon dioxide to give the carboxylic acid of general formula III. The carboxylation may conveniently be carried out using solid carbon dioxide ("dry ice") or by passing gaseous carbon dioxide into the reaction mixture. Examples of suitable solvents for this reaction are any of the aforementioned solvents which can be used to prepare the anion, with the exception of liquid ammonia which is basic and dimethyl sulfoxide which appears to promote decarboxylation. In cases where liquid ammonia or dimethylsulfoxide is used to prepare the anion, they should be replaced with an inert solvent when carrying out the carbon dioxide treatment. Suitable reaction temperatures range from -60 ° C to approx. 40 ° C. The reaction is preferably carried out initially at the lower end of this range for a period of approx. 6 hours, after which the reaction mixture is allowed to warm to approximately room temperature over 4 hours and then left at room temperature for another 12 hours. The separation of the desired reaction product from the reaction mixture can be carried out by extraction. The extraction is conveniently carried out from a hydrocarbon solvent having a dilute base such as sodium hydroxide or lithium carbonate to form the corresponding water-soluble salt of the acid. Base extraction is used to remove the desired product from the starting material. The aqueous phase is separated and gently acidified to a pH of between 2.5 and 4.5 with dilute mineral acid, after which the desired product is obtained by conventional methods. Although the reaction can be conveniently carried out at atmospheric pressure, higher yields can be obtained by carrying out the reaction under higher pressure, e.g. pressure in the range of 30 - 40 kg / cm 2.

De optiske antipoder af de omhandlede forbindelser kan fås enten ved opspaltning af det tilsvarende racemiske slutprodukt eller ved* opspaltning af racemisk udgangsmateriale eller, såfremt der ved fremgangsmåden ifølge opfindelsen direkte anvendes racemisk udgangsmateriale, ved opspaltning af et hvilket som helst som. mellemprodukt vundet racemat. Ved opfindelsen tilvejebringes der en simpel syntese for optisk aktive slutprodukter på grund af det forhold, at den optiske specificitet bevares under hele . syntesen som følge af stereoselektiviteten af de enkelte ved fremgangsmåden stedfindende omdannelser, som de ovennævnte re= aktioner er eksempler på. Opspaltningen kan udføres ved konven= tionelle kendte-opspaltningsmetoder. Således kan f.eks. racema= ter af forbindelser, hvor den del, der symboliseres' ved symbolet 'Z, er hydroxymethylen,eller en .gruppe, der kan omdannes til hy= droxymethylen, f.eksi carbonyl (som ved reduktion kan omdannes til hydroxymethylen) eller en ether eller ester af hydroxymethy= len (som ved hydrolyse kan omdannes til hydroxymethylen) opspal= tes ved omsætning af forbindelsen indeholdende hydroxymethylen= delen med en tobasisk syre, f.eksi med en tobasisk lavere alkan= carboxylsyre såsom oxalsyre, malonsyre, ravsyre, glutarsyre eller • adipinsyre, eller en aromatisk tobasisk syre såsom phthalsyre, omsætning af den på denne måde dannede halvester med en optisk 9 142053 aktiv base såsom brucin, ephé&rin eller quinin, og adskillelse af de resulterende diastereoisomere produkter. Alternativt kan hydrosymethylengruppen esterificeres med en optisk aktiv syre, f.eks. camphersulfonsyre, og de resulterende diastereoisomere estere kan adskilles. De optiske antipoder kan på konventionel måde gendannes ud fra de adskilte diastereoisomere salte og ' estere.The optical antipodes of the subject compounds can be obtained either by cleavage of the corresponding racemic final product or by cleavage of racemic starting material or, if the racemic starting material is used directly, by cleavage of any one. intermediate won race food. The invention provides a simple synthesis for optically active end products due to the fact that the optical specificity is maintained throughout. the synthesis due to the stereoselectivity of the individual conversions occurring in the process, of which the above reactions are examples. The cleavage can be carried out by conventional known cleavage methods. Thus, e.g. racemates of compounds wherein the part symbolized 'by the symbol' Z is hydroxymethylene, or a group which can be converted to hydroxymethylene, for example carbonyl (which can be converted to hydroxymethylene by reduction) or an ether or ester of the hydroxymethylene (which can be converted to hydroxymethylene by hydrolysis) is cleaved by reacting the compound containing the hydroxymethylene moiety with a tobacic acid, for example with a tobasic lower alkanoic carboxylic acid such as oxalic acid, malonic acid, succinic acid, glutaric acid or Adipic acid, or an aromatic tobasic acid such as phthalic acid, reacting the thus-formed half-ester with an optically active base such as brucine, ephedrine or quinine, and separation of the resulting diastereoisomeric products. Alternatively, the hydrosymethylene group can be esterified with an optically active acid, e.g. camphor sulfonic acid and the resulting diastereoisomeric esters can be separated. Conventionally, the optical antibodies can be recovered from the separated diastereoisomeric salts and esters.

De omhandlede forbindelser er nyttige mellemprodukter i total= syntesen af kendte og hidtil ukendte farmakologisk værdifulde steroider, f.eks. 19-nor-steroider som beskrevet i eksemplerne i dansk patentansøgning nr. 5252/69. Det nedenstående reaktionsske= ma illustrerer den videre omdannelse af en forbindelse med den al= mene formel I til 19-nor-steroider, f.eks. 19-nor-testosteron. I dette reaktionsskema har R2 og R^ de ovenfor anførte betydninger, og W betegner resten af ketaldelen, f.eks. en alkylengruppe.The present compounds are useful intermediates in the total synthesis of known and novel pharmacologically valuable steroids, e.g. 19-nor-steroids as described in the examples in Danish Patent Application No. 5252/69. The reaction scheme below illustrates the further conversion of a compound of general formula I to 19-norsteroids, e.g. 19-nor-testosterone. In this reaction scheme, R 2 and R 2 have the meanings given above, and W represents the rest of the ketal moiety, e.g. an alkylene group.

α η ηΛ 142053 Η 10 · > Η ^ Μ & /- ^ W / -1—W.α η ηΛ 142053 Η 10 ·> Η ^ Μ & / - ^ W / -1 — W.

<Μ /- Μ /7 \ §_ί . · Η (“7-\ / \'w νΛ / / O o \ <0 \ / N-' o o \ / ^ <M /- — °—(<Μ / - Μ / 7 \ §_ί. · Η (“7- \ / \ 'w νΛ / / O o \ <0 \ / N-' o o \ / ^ <M / - - ° - (

~^pj \-----M~ ^ pj \ ----- M

1 jP i/H s/ ΜΛ1 jP i / H s / ΜΛ

1 . ^81 · vU-« / (V1. ^ 81 · vU- «/ (V

Ϊ r\ v/\ a * SC s H \ v a o \ ° \Ϊ r \ v / \ a * SC s H \ v a o \ ° \

v Av A

. o o + w. o o + w

+ fe H+ fe H

HH

/- H/ - H

CJ / i> W_/ O \ '%i——U-w w r— / W-Λ-- .CJ / i> W_ / O \ '% i —— U-w w r— / W-Λ--.

^- \ «8 \ / w V--V-a ^cM h^ - \ «8 \ / w V - V-a ^ cM h

No /\ o oNo / \ o o

VV

11 14205311 142053

Ved Michael-additionen, fremgangsmådetrin (a) i ovenstående reaktionsskema, opbygges forløberne for steroidringene A og B i en enkelt ringdannelsesreaktion. Reaktionen udføres i nærvæ= relse af en base, som er tilstrækkelig stærk til at danne anio= nen af β-ketoesteren. Eksempler på egnede baser er lavere alka= . limetalalkoxider, f.eks. natriummethoxid, natriumethoxid, ka= liummethoxid eller kalium-tert.butoxid, alkalimetalbydroxider såsom natriumhydroxid, alkalimetalhydrider såsom natriumhydrid og lithiumhydrid, alkalimetalamider såsom lithiumamid og natri= umamid samt methylsulfinylcarbanion (dvs. anionen af dimethyls sulfoxid). Især foretrækkes de lavere alkalimetalalkoxider. Re= aktionen kan udføres i et temperaturområde fra ca. -5°C til • i ca. 100°C, men det er særlig fordelagtigt at udføre reaktionen i' et temperaturområde fra 0°C til 25°C. Endvidere udføres reak= tionen hensigtsmæssigt i fraværelse af oxygen, f.eks. i en at= mosfære af indifferent gas såsom nitrogen eller argon. Eet er hensigtsmæssigt at udføre reaktionen i nærværelse af et organisk opløsningsmiddel, som er indifferent over for reaktanterne og over for mellemprodukterne med den almene formel VII. Sådanne opløsningsmidler er f.eks. dimethylformamid, dimethyleulfoxid og aromatiske carbonhydrider, f.eks. benzen, toluen og xylen.By the Michael addition, process step (a) of the above reaction scheme, the precursors of steroid rings A and B are built up in a single ring formation reaction. The reaction is carried out in the presence of a base sufficiently strong to form the anion of the β-keto ester. Examples of suitable bases are lower alka =. limetal alkoxides, e.g. sodium methoxide, sodium ethoxide, potassium methoxide or potassium tert.butoxide, alkali metal hydroxides such as sodium hydroxide, alkali metal hydrides such as sodium hydride and lithium hydride, alkali metal amides such as lithium amide and sodium amide, and methylsulfinylcarbanion (i.e. In particular, the lower alkali metal alkoxides are preferred. The reaction can be carried out in a temperature range of approx. -5 ° C to • for approx. 100 ° C, but it is particularly advantageous to carry out the reaction in a temperature range from 0 ° C to 25 ° C. Furthermore, the reaction is conveniently carried out in the absence of oxygen, e.g. in an atmosphere of inert gas such as nitrogen or argon. It is convenient to carry out the reaction in the presence of an organic solvent which is inert to the reactants and to the intermediates of the general formula VII. Such solvents are e.g. dimethylformamide, dimethyl sulfoxide and aromatic hydrocarbons, e.g. benzene, toluene and xylene.

Andre egnede opløsningsmidler er etherne såsom diethylether og tetrahydrofuran og lavere alkanoler såsom methanol og ethanol. Reaktanternes koncentration er ikke kritisk, men det foretrækkes at anvende et molforhold på 1:1 mellem reaktanterne med formlerne la og VI. Sidekæden i reaktionsmellemproduktet VII antager den termodynamisk gunstige ækvatoriale konfiguration under ækvilibre= ringsreaktionsbetingelserne. Sidekædens α-orientering er yderst vigtig for opbygningen af ring B med den rigtige stereokemi.Other suitable solvents are the ethers such as diethyl ether and tetrahydrofuran and lower alkanols such as methanol and ethanol. The concentration of the reactants is not critical, but it is preferred to use a 1: 1 molar ratio of the reactants of formulas Ia and VI. The side chain of the reaction intermediate VII assumes the thermodynamically favorable equatorial configuration under the equilibrium reaction conditions. The side orientation α orientation is extremely important for the construction of ring B with the right stereochemistry.

På grund af den foretrukne enolisering af ketogruppen i retning mod esterfunktionen sker der ingen ringslutning på dette stadium.Due to the preferred enolization of the keto group towards the ester function, no cycling occurs at this stage.

Efter Michael-additionen af β-ketoesteren med den almene formel VI til den bicycliske trans-indanon med den almene formel la hys drolyseres de på denne måde vundne forbindelser med den almene formel VII til fjernelse af estergruppen, hvorefter de cycliseres • efter trin (b) i reaktionsskemaet. Cycliseringen bør udføres under reaktionsbetingelser, som ikke medfører spaltning af den beslcytten= de cycliske ketalgruppe. Eksempler på basiske cycliseringsmidler er f.eks. en fortyndet vandig opløsning af alkalimetalhydroxider 12 . 142053 eller jordalkalimetalhydroxid. Cycliseringen udføres hensigtsmæs= sigt i et indifferent organisk opløsningsmiddel, f.eks. carbon= hydrider såsom benzen og toluen, og ethere såsom tetrahydrofuran. Cycliseringen kan udføres ved stuetemperatur eller ved tempera= turer over stuetemperatur, men det foretrækkes af bekvemmelig= hedsgrunde at udføre reaktionen ved omtrentlig stuetemperatur. Estergruppen i det bicycliske mellemprodukt med den almene for= mel VII kan fjernes ved hydrolyse af· esteren efter trin (b) i reaktionsskemaet til dannelse af den tilsvarende syre med den al= mene formel VIII (efter syrning) og decarboxylering til forbindel= ser med den almene formel IX, f.eks. i tilbagesvalende toluen under indifferent atmosfære, f.eks. nitrogen, i henhold til trin (c) i reaktionsskemaet.Following the Michael addition of the β-keto ester of the general formula VI to the bicyclic trans-indanone of the general formula la hys, the compounds thus obtained with the general formula VII are drolyzed to remove the ester group and then cyclized after step (b). ) in the reaction scheme. The cyclization should be carried out under reaction conditions which do not result in cleavage of the cyclic ketal group. Examples of basic cyclizing agents are e.g. a dilute aqueous solution of alkali metal hydroxides 12. 142053 or alkaline earth metal hydroxide. The cyclization is conveniently carried out in an inert organic solvent, e.g. carbon = hydrides such as benzene and toluene, and ethers such as tetrahydrofuran. The cyclization can be carried out at room temperature or at temperatures above room temperature, but it is preferable for convenience reasons to carry out the reaction at approximate room temperature. The ester group of the bicyclic intermediate of the general formula VII can be removed by hydrolysis of the ester following step (b) of the reaction scheme to form the corresponding acid of general formula VIII (after acidification) and decarboxylation to compounds with the general formula IX, e.g. in refluxing toluene under inert atmosphere, e.g. nitrogen, according to step (c) of the reaction scheme.

Hydrogeneringen af ^^-dobbeltbindingen ^ forbindelser med den almene formel IX til dannelse af forbindelser med den almene formel X kan udføres ved trin (d) i reaktionsskemaet i et lavere alkoholopløsningsmiddel,*f.eks. ethylalkohol, i nærværelse af en base, fortrinsvis triethylamin. 19-Ror-testosteron kan frem= stilles ud fra forbindelserne med den almene formel X ved hydro= lyse og cyelisering ved tilbagesvaling i en mineralsyre såsom saltsyre eller svovlsyre i et lavere alkanolopløsningsmiddel så= som methanol i overensstemmelse med trin (e) i reaktionsskemaet.The hydrogenation of the ³ - double bond forbind compounds of the general formula IX to form compounds of the general formula X can be carried out by step (d) of the reaction scheme in a lower alcohol solvent, e.g. ethyl alcohol, in the presence of a base, preferably triethylamine. 19-Ror testosterone may be prepared from the compounds of the general formula X by hydrolysis and refluxing in a mineral acid such as hydrochloric or sulfuric acid in a lower alkanol solvent such as methanol according to step (e) of the reaction scheme.

Eet skal bemærkes, at de fremgangsmådetrin, der er vist i reak= tionsskemaet, kan anvendes til· fremstilling af norgestrel. Eette kan ske ved at fremstille de 7 aβ-ethylanaloge af forbindelsen méd formlen la under anvendelse af reaktionstrinnene (a), (b), (c), (d) og (e) i reaktionsskemaet efterfulgt af oxidation under anvendelse af f.eks. Jones-reagens og ethynylering. Eet vil end= videre forstås, at man ved at anvende den'optisk aktive 7ap-ethyl= -enanthiomere af forbindelser med den almene formel la i reakti= onsskemaet kan fremstille optisk aktivt norgestrel.It should be noted that the process steps shown in the reaction scheme can be used to prepare norgestrel. This may be accomplished by preparing the 7 αβ-ethyl analogs of the compound of formula Ia using the reaction steps (a), (b), (c), (d) and (e) of the reaction scheme followed by oxidation using e.g. . Jones reagent and ethynylation. It will further be understood that by using the optically active 7ap-ethyl = -enanthiomers of compounds of the general formula Ia in the reaction scheme, optically active norgestrel can be prepared.

Fremgangsmåden ifølge opfindelsen belyses nærmere ved det følgende eksempel.· I de tilfælde, hvor der er taget IR-, UV- og MR-spektre, har de stemt overens med de angivne strukturer.The method according to the invention is illustrated in more detail by the following example.

13 14205313 142053

Eksempel.Example.

A.A.

45 ml dimethylsulfoxid destilleret over calciumhyurid sættes til en 53$'s dispersion af 1,05 g natriumhydrid i mineralolie, som i forvejen er vasket med vandfri ether og tørret under nitrogen= atmosfære. Blandingen omrøres ved 20°Cr og der tilsættes på én gang en opløsning af 5,0 g ip-tert.butoxy~5,6,7,7a-tetrahydro= -*7ηβ-ηΐθΐ1^1·-5-οχο-1η1ηη i 45 ml dimethylsulfoxid. Reaktions= blandingen omrøres, indtil hydrogenudviklingen går i stå, og der= efter i ca. 4 timer. Derpå afdestilleres diméthylsulfoxidet under højvakuum under anvendelse af et bad, som holdes ved en temperatur på 75°C. Remanensen (konjugatanion af ip-tert.butoxy-5,6,7,7a=* -tetrahydro-7a6-methyl-5-oxo·-indan) opløses i 90 ml vandfri ether og sættes så hurtigt som muligt (i. løbet af 2 minutter) til .en ' 1 liters kolbe indeholdende en, tyk opslæmning af vandfrit fast carbondioxid i 225 ml vandfrit ether. Reaktionsblandingen omrø= res kraftigt. Opslæmningen er fremstillet ved at afkøle 2 - 5 ml45 ml of dimethyl sulfoxide distilled over calcium hyuride is added to a $ 53 dispersion of 1.05 g of sodium hydride in mineral oil, which is already washed with anhydrous ether and dried under nitrogen = atmosphere. The mixture is stirred at 20 ° Cr and a solution of 5.0 g of ip-tert.butoxy ~ 5,6,7,7a-tetrahydro = - * 7ηβ-ηΐθΐ1 ^ 1 · -5-οχο-1η1ηη is added at once. 45 ml of dimethyl sulfoxide. The reaction = the mixture is stirred until the hydrogen evolution is stopped and thereafter = for approx. 4 hours. The dimethyl sulfoxide is then distilled off under high vacuum using a bath maintained at a temperature of 75 ° C. The residue (conjugate anion of ip-tert.butoxy-5,6,7,7a = * -tetrahydro-7a6-methyl-5-oxo · -indane) is dissolved in 90 ml of anhydrous ether and added as soon as possible (during 2 minutes) into a 1 liter flask containing a thick slurry of anhydrous solid carbon dioxide in 225 ml of anhydrous ether. The reaction mixture is stirred vigorously. The slurry is prepared by cooling 2 - 5 ml

f - Jf - J

vandfri ether med en køleblanding af tøris og methanol og deref= ter tilsætte vandfrit fast carbondioxid fra en omvendt beholder indeholdende "knastørt" carbondioxid. Beholderen står ved hjælp af kautsjuktrykrør i forbindelse med kolben. 2 afgange er forbun= det med to tørre tårne fyldt med vandfrit calciumsulfat. Efter= _ hånden som opslæmningen dannes og tykner, tilsættes der lidt efter lidt tørt ether fra en dryppetragt, indtil der i alt er tilsat 225 ml. Reaktionsblandingen omrøres i 6 timer i et kølebad af tøriB og methanol og henstår i 16 timer ved 20°0. lil etheropløsnlngen sættes 200 ml vand indeholdende 50 ml 0,1R natriumhydroxid, og der omrøres i 1 time under nitrogenatmosfære. Etherfasen og vandfasen adskilles, og etherfasen vaskes to gange med vand.anhydrous ether with a cooling mixture of dry ice and methanol and then adding anhydrous solid carbon dioxide from an inverted container containing "crushed" carbon dioxide. The container stands by means of rubber pressure pipes in connection with the flask. 2 departures are connected to it with two dry towers filled with anhydrous calcium sulfate. After the hand as the slurry is formed and thickens, little by little dry ether is added from a drip funnel until a total of 225 ml is added. The reaction mixture is stirred for 6 hours in a cooling bath of dry B and methanol and left for 16 hours at 20 ° 0. To the ether solution is added 200 ml of water containing 50 ml of 0.1 R sodium hydroxide and stirred for 1 hour under a nitrogen atmosphere. The ether phase and water phase are separated and the ether phase is washed twice with water.

Den kombinerede vandige fraktion ekstraheres med ether. De kombinerede etherekstrakter tørres over natriumsulfat og.ind= dampes i vakuum, hvorved der fås udgangsmateriale, Ιβ-tert.::: butoxy-5,6,7,7η-ΐθΐηη1^ηο-7ηβ-:αΐθ1]^Γΐ···5-·οχο-1η1ηη. Den vandige opløsning filtreres og syrnes forsigtigt med 2N saltsyre til pH-værdi 2,5 ved en temperatur på ca. 0°0. Blandingen ekstrahe= 142053 14 res to gange mel benzen og derefter med ether, og ekstrakten vaskes med mættet natriumchloridopløsnihg, tørres over natriumsulfat, filtreres og inddampes i vakuum, hvorved der i form af et tørt fast stof fås β-ketosyrén, Ιβ-tert.butoxy-5,6,7,7a-tetrahydro-7aP-methyl--5-oxq-4-indan-carloxy 1syre med smeltepunkt 153 - 160° 0. Ved findeling med ether fås ip-tert.bu'toxy-5j6,7,7a-tetrahydro-7aP= -methyl-5-QXo-4~indan-carboxylsyre med smeltepunkt 156°C.The combined aqueous fraction is extracted with ether. The combined ether extracts are dried over sodium sulfate and evaporated in vacuo to give the starting material, tβ-tert. ::: butoxy-5,6,7,7η-ΐθΐηη1 ^ ηο-7ηβ-: αΐθ1] ^ Γΐ ··· · 5- οχο-1η1ηη. The aqueous solution is filtered and gently acidified with 2N hydrochloric acid to pH 2.5 at a temperature of approx. 0 ° 0th The mixture is extracted twice with benzene and then with ether, and the extract is washed with saturated sodium chloride solution, dried over sodium sulfate, filtered and evaporated in vacuo to give the β-ketosyrene, β-tert, in the form of a dry solid. butoxy-5,6,7,7a-tetrahydro-7aP-methyl-5-oxo-4-indanecarloxylic acid, m.p. 153-160 ° 0. In trituration with ether, ip-tert.butoxy-5β, 7,7a-tetrahydro-7aP = -methyl-5-QXo-4-indanecarboxylic acid, mp 156 ° C.

Ved rekrystallisation af acetone fås en analytisk ren prøve af Ιβ-tert.butoxy-$,6,7,7a-tetrahydro-7aP-methyl-5-oxo-4-indan= -carboxylsyre, smeltepunkt 159,5°C.Recrystallization of acetone gives an analytically pure sample of Ιβ-tert.butoxy - $, 6,7,7a-tetrahydro-7aP-methyl-5-oxo-4-indane = carboxylic acid, mp 159.5 ° C.

B.B.

1,84 g umættet β-ketosyre, lp-tert.butoxy-5,6,7,7a-tetrahydro= -7ηβ-methyl-5-oxo-4-indan-carboxy1syre, opløses i 92 ml absolut ethanol og hydrogeneres ved atmosfæretryk og stuetemperatur i * nærværelse af 184 mg 10 vægt$1 s palladium/bariumsulfat-katalysa= tor. Den. teoretiske hydrogenmængde forbruges i løbet af 20 mi= nutter. Opløsningen filtreres og inddampes i vakuum, hvorved der fås iP-tert.butoxy-3aa-4P-5,6,7,?a-hexahydro-7aP-methyl-5-oxo= -4a-indan-carbaxylsyre med smeltepunkt 107,5 - 109°C. En analy= tisk ren prøve af Ιβ-tert.butoxy-3aa,4β,5,6,7,7a-hexahydro-7aβ= -methyl-5-oxo-4a-indan-carboxylsyre fås ved omkrystallisation af ether og har smeltepunkt 114 - 114,5°C.1.84 g of unsaturated β-keto acid, 1β-tert.butoxy-5,6,7,7a-tetrahydro = -7ηβ-methyl-5-oxo-4-indanecarboxylic acid, dissolved in 92 ml of absolute ethanol and hydrogenated at atmospheric pressure and room temperature in the presence of 184 mg of 10 wt $ 1 s palladium / barium sulfate catalyst. The. theoretical amount of hydrogen is consumed over 20 mi = nuts. The solution is filtered and evaporated in vacuo to give iP-tert.butoxy-3aa-4P-5,6,7, α-hexahydro-7aP-methyl-5-oxo = -4a-indanecarboxylic acid, mp 107.5 - 109 ° C. An analytically pure sample of β-tert-butoxy-3aa, 4β, 5,6,7,7a-hexahydro-7aβ = -methyl-5-oxo-4a-indanecarboxylic acid is obtained by recrystallization from ether and has a melting point of 114 - 114.5 ° C.

G.G.

2,95 g Ιβ-tert,butoxy-Ja«^»5,6,7,7η-ηβΧθ1ητάηο-7ηβ-πιβΐ1]$-1-5- -oxo-4a-indan-carboxylsyre opløses i en blanding af 22 ml di= methylsulfoxid og 12,2 ml 36 - 38$* s vandig formaldehydopløsning.2.95 g of Ιβ-tert, butoxy-Ja «^ 5,6,7,7η-ηβΧθ1ητάηο-7ηβ-πιβΐ1] $ -1-5- = methyl sulfoxide and 12.2 ml of 36 - 38 $ * aqueous formaldehyde solution.

Der tilsættes 1,35 g piperidinhydrochlorid, og blandingen omrø= res under nitrogen'i 3 timer. lil den ovennævnte regktionsblan= ding tilsættes 9,35 mg natriumbicarbonat χ χοο ml vand, hvorpå " blandingen ekstraheres 3 gange med benzen. Ekstrakten vaskes med vand og med en mættet natriumchloridopløsning, tørres over mag= nesiumsulfat og filtreres, hvorpå den inddampes i vakuum til dannelse åf råt lp-tert.butoxy-^actjS,7,7a-tetrahydro-7aP-methyl= -4~methylen-indan-5(4H)-on i form af en olie. Den rå methylen=1.35 g of piperidine hydrochloride is added and the mixture is stirred under nitrogen for 3 hours. To the above-mentioned mixture is added 9.35 mg of sodium bicarbonate χ οο ml of water, then the mixture is extracted 3 times with benzene. The extract is washed with water and a saturated sodium chloride solution, dried over magnesium sulfate and filtered and evaporated formation of crude lp-tert.butoxyactax, 7,7a-tetrahydro-7aP-methyl = -4 ~ methylene-indan-5 (4H) -one in the form of an oil.

Claims (1)

1. Fremgangsmåde til fremstilling af racemiske eller optisk aktive indan- eller perhydronaphthalenderivater med den almene formel I S4 ο'ίίίί[ί H ch2 hvor R4 betegner hydrogen eller alkyl med 1-7 carbonatomer, Z betegner carbonyl, alkylendioxymethylen méd 1-6 carbonatomer i alkylendelen eller CH(0R ), R betegner hydrogen, alkyl med 1 - 7 carbonatomer, alkoxyalkyl med 1-7 carbonatomer i hver alkyldel, ! phenylalkyl med 1-7 carbonatomer i alkyldelen, alkanoyl med 1-6 carbonatomer, benzoyl, nitrobenzoyl med 1 eller 2 nitrogrup= per, trifluoracetyl eller camphersulfonyl, og m betegner 1 eller 2, kendetegnet ved, at man hydrogenerer en forbindelse med den almene formel IIIA process for the preparation of racemic or optically active indane or perhydronaphthalene derivatives of the general formula I S4 ο'ίίίί [ί H ch 2 wherein R 4 represents hydrogen or alkyl of 1-7 carbon atoms, Z represents carbonyl, alkylenedioxymethylene with 1-6 carbon atoms. the alkylene moiety or CH (OR), R represents hydrogen, alkyl of 1-7 carbon atoms, alkoxyalkyl of 1-7 carbon atoms in each alkyl moiety, phenylalkyl of 1-7 carbon atoms in the alkyl moiety, alkanoyl of 1-6 carbon atoms, benzoyl, nitrobenzoyl of 1 or 2 nitro groups, trifluoroacetyl or camphorsulfonyl, and m represents 1 or 2, characterized by hydrogenating a compound of the general formula III
DK154372A 1968-10-04 1972-03-29 Process for preparing racemic or optically active indane or perhydronaphthalene derivatives. DK142053B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK154372A DK142053B (en) 1968-10-04 1972-03-29 Process for preparing racemic or optically active indane or perhydronaphthalene derivatives.

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US765023A US3897460A (en) 1968-10-04 1968-10-04 3{62 -Tertiarybutoxy-decahydro-benz{8 E{9 indenes
US76502368 1968-10-04
DK525269AA DK138638B (en) 1968-10-04 1969-10-02 Indane derivatives for use as intermediates in the preparation of 19-nor-steroids.
DK525269 1969-10-02
DK154372A DK142053B (en) 1968-10-04 1972-03-29 Process for preparing racemic or optically active indane or perhydronaphthalene derivatives.
DK154372 1972-03-29

Publications (2)

Publication Number Publication Date
DK142053B true DK142053B (en) 1980-08-18
DK142053C DK142053C (en) 1981-01-12

Family

ID=27221330

Family Applications (1)

Application Number Title Priority Date Filing Date
DK154372A DK142053B (en) 1968-10-04 1972-03-29 Process for preparing racemic or optically active indane or perhydronaphthalene derivatives.

Country Status (1)

Country Link
DK (1) DK142053B (en)

Also Published As

Publication number Publication date
DK142053C (en) 1981-01-12

Similar Documents

Publication Publication Date Title
Parker et al. Total synthesis of dl-avenaciolide
MX2007012446A (en) Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6, 7]oxepino[4,5-c]pyrrole.
FI57253C (en) FRAMEWORK FOR THE PRODUCTION OF PHARMACODYNAMIC ACTIVE BASIC SUBSTITUTION INDICATORS
NO140977B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-AMINO-1,4-DIHYDROPYRIDINES
US3538120A (en) Cyclopentyl-alkanoic acids
CLAUSON-KAAS New examples of electrolytic methoxylation of furans
US3984473A (en) Stereospecific total steroidal synthesis via substituted C/D-trans indanones
DK142053B (en) Process for preparing racemic or optically active indane or perhydronaphthalene derivatives.
US3897460A (en) 3{62 -Tertiarybutoxy-decahydro-benz{8 E{9 indenes
US2931805A (en) Spiro [bicyclo [2. 2. 1] heptane-2, 2&#39;-alkylenimines]
Belleau et al. Stereoselective Synthesis of a Dibenzo [a, g] quinolizine Analog of 18-Hydroxyepialloyohimbane
CS202044B2 (en) Method of preparation of 2-arylpropione acids
Nakano et al. Total synthesis of methynolide: Synthesis of two intermediates, 3, 4-diacetoxy-3-methyl-1-hexyne and Prelog-Djerassi lactonic acid.
US3925478A (en) Stereospecific total steroidal synthesis via substituted C/D-trans indanones
US4017545A (en) Process for the preparation of bicycloalkane derivatives
US4093619A (en) Method for oxidizing cinchona alkaloids
US3929876A (en) Stereospecific total steroidal synthesis via substituted C/D-trans indanones
US4024166A (en) Process for the preparation of 13β-alkyl-4-gonene-3,17-diones
US3868402A (en) Novel cyclopentanone-2-carboxylates
DE1950012C2 (en) New tricyclic compounds and their preparation
US2701250A (en) Process of producing indole-3-acetic acids
US3927031A (en) Stereospecific total steroidal synthesis via substituted C/D-trans indanones
LUTZ et al. THE CIS AND TRANS 3-AROYL-2, 3-DIMETHYLACRYLIC1 ACIDS WITH PARTICULAR REFERENCE TO THE OPEN-CHAIN AND CYCLIC FORMS OF THE CIS DERIVATIVES
DK150473B (en) RACEMIC OR OPTICALLY ACTIVE PERHYDROINDANES USED AS INTERMEDIATES IN THE MANUFACTURE OF 19-NOR STEROIDS
US4032577A (en) Unsaturated ketones

Legal Events

Date Code Title Description
PBP Patent lapsed